Walf-Vorderwülbecke et al. used a c-MYB gene expression signature from AML cells to probe a library containing over 1,500,000 gene expression profiles and identified MBZ as the most efficient c-MYB targeting drug [45]. This evidence concerns the gene MYB and acute myeloid leukemia.